glp 1 dual agonist Mechanisms of action of GLP-1 RA and GLP-1/GIP agonists. ↑: GLP-1 Agonists For Obesity In

Description

The injectable medication has reportedly also found popularity among Silicon Valley execs, like Sheryl Sandberg and Mark Zuckerberg

Additionally, these are not components of FDA-approved drugs and have not been found safe and effective for any condition. At this time, these drugs are only legally accessible to clinical trial patients

While several reviews on this topic exist, this article aims to provide a distinct, up-to-the-minute synthesis that addresses the needs identified by recent expert commentary

persistent, severe abdominal pain) Hypersensitivity to DPP-4 inhibitors in the past Pregnancy/breastfeeding Some DPP-4 inhibitors are contraindicated at certain thresholds of renal impairment (see Table 2 ) Some DPP-4 inhibitors are contraindicated in hepatic impairment (see Table 3 ) Type 1 diabetes Diabetic ketoacidosis Cautions History of pancreatitis Moderate heart failure (saxagliptin only, due to limited experience) Severe heart failure (saxagliptin and vildagliptin, due to limited experience) Some DPP-4 inhibitors are cautioned at certain thresholds of renal impairment, and dose reductions may be required (see Table 2 ) Drug interactions No significant interactions have been reported between DPP-4 inhibitors and any other drugs